Top-tier raw materials for specialized pain reduction and inflammation management.
In the contemporary pharmaceutical and nutraceutical landscape, the term "Pain Reducer" has evolved beyond simple synthetic analgesics. Today, the global market is shifting toward Phyto-pharmaceuticals and multi-modal anti-inflammatory agents that address pain at its molecular source without the side effects of traditional NSAIDs.
As a leading OEM Pain Reducer Supplier, Shaanxi Bieyouth Biotech Co., Ltd. recognizes that "Pain Reduction" now encompasses topical skin soothing (utilizing botanical extracts like Tetrandrine), joint mobility support (via Anserine), and oxidative stress management. The search intent for high-quality suppliers is no longer just about volume—it is about bioavailability, purity (99%+), and sustainable extraction.
The global analgesic market is projected to reach USD 91.6 billion by 2027. This growth is driven by an aging global population and a rising preference for natural-origin active pharmaceutical ingredients (APIs). Our factory serves as a critical node in this supply chain, bridging the gap between raw botanical power and clinical-grade application.
Established in 2018, Shaanxi Bieyouth Biotech Co., Ltd. is a premier gold supplier specializing in the R&D, production, and global distribution of plant and animal extracts, food additives, and pharmaceutical raw materials. Our commitment to the "Pain Reducer" vertical is evidenced by our GMP-certified production facilities and advanced extraction technologies.
How we leverage technology to ensure stability in the global pain reducer market.
Enterprises in the US, EU, and Russia are increasingly seeking transparent supply chains. We meet this demand by providing full traceability and documentation (COA, MSDS, GMP).
Our "Factory 4.0" approach integrates IoT monitoring in our extraction workshops, ensuring that temperature-sensitive compounds like PSGAG maintain 100% molecular integrity.
By controlling the source (direct botanical cultivation) and the end-process, we mitigate the risks of price volatility in the pain management ingredient market.
Converting raw science into market-ready analgesic solutions.
Deep dive into your target demographic—whether it's geriatric joint care or post-procedural skin recovery.
Utilizing our Institute of Biology (est. 2020) to create synergistic blends of natural and pharmaceutical agents.
Accelerated aging tests ensure your "Pain Reducer" product has a robust shelf life and consistent efficacy.
Mass production in our two standardized workshops with strict adherence to FDA and international standards.
Seamless export to the USA, UK, Canada, Russia, and Australia with expert customs clearance support.
Join over 1,000+ satisfied global clients who trust our production excellence.
Participated in Shanghai International Cosmetics, Personal and Home care Raw Materials exhibition.
Obtained FDA certificate, opening the door for high-level pharmaceutical export.
Launch of Biology Institute for cosmetic raw material research & Global Trade Expansion.
Awarded "Integrity Enterprise" and "Quality Assured Enterprise" titles.
Where our "Pain Reducer" and high-purity ingredients make the most impact.
Our GMP DMF Grade PSGAG and Leuprolide Acetate are used in clinical settings for metabolic pain management and hormonal therapy. High purity is non-negotiable here.
Ingredients like Tetrandrine and Ceramide NP3 are integrated into "anti-stress" creams to reduce skin sensitivity—a form of localized "pain" or discomfort reduction.
The aging pet population requires high-purity joint support. Anserine and PSGAG are becoming staples in the premium pet supplement market.
Inulin and Pomegranate Extract address systemic inflammation, reducing the long-term risk of chronic pain associated with metabolic disorders.
Reliability stems from our GMP certification and FDA registration. We offer information gain through our internal R&D lab, providing not just the raw material but the stability data and formulation support required for high-stakes pharmaceutical applications.
Yes. For ingredients like Dihydromyricetin or Glutathione, we can provide specific assay levels (e.g., 98% vs 99.9%) depending on whether the end-use is a dietary supplement or a medical-grade injection.
We maintain a 50,000-ton annual capacity and strategic raw material reserves. This allows us to offer Factory Direct Pricing even during global market fluctuations, ensuring our clients maintain their competitive edge.
Our research suggests that Tetrandrine (botanically derived) and Nymphaea Coerulea Extract offer superior soothing properties by modulating the skin's inflammatory response pathways.
Global service with local expertise. Meet the people behind your supply chain success.
Penny
Angel Wang
Monica Li
Margaret Zhang
Felix Liang
Shaanxi Bieyouth Biotech Co.,Ltd. – Your Trusted Partner in Pain Reducer OEM/ODM Manufacturing.
Bieyouth
